How well can blood pressure be controlled? Progress report on the Systolic Hypertension in Europe Follow-Up Study (Syst-Eur 2)
暂无分享,去创建一个
Jan A Staessen | Jaakko Tuomilehto | Lutgarde Thijs | Cinzia Sarti | Robert H Fagard | C. Bulpitt | J. Tuomilehto | J. Staessen | L. Thijs | A. Fletcher | R. Fagard | C. Sarti | C. Nachev | W. Birkenhäger | H. Celis | G. Leonetti | T. Laks | Christopher J Bulpitt | Astrid E Fletcher | Hilde Celis | Willem H Birkenhäger | Gastone Leonetti | Choudomir Nachev | Sonia Beleva | Rumjana Kermova | Tovio Laks | Stefan Mantov | S. Mantov | S. Beleva | Rumjana Kermova
[1] Shanghai trial of nifedipine in the elderly (STONE). , 1996, Journal of hypertension.
[2] Chung-Sheng Li,et al. Steering committee , 2018, 2009 5th International Conference on Collaborative Computing: Networking, Applications and Worksharing.
[3] Jan A Staessen,et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension , 1997, The Lancet.
[4] Detection. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) , 1997 .
[5] N. Kaplan. New issues in the treatment of isolated systolic hypertension. , 2000, Circulation.
[6] Barry R. Davis,et al. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group. , 2000, JAMA.
[7] K. Heilbrun,et al. Ethics by committee? , 1987, The New England journal of medicine.
[8] Giuseppe Mancia,et al. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT) , 2000, The Lancet.
[9] Thomas Hedner,et al. Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study , 2000, The Lancet.
[10] T. Hedner,et al. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study , 1999, The Lancet.
[11] R B Haynes,et al. 1999 Canadian recommendations for the management of hypertension. Task Force for the Development of the 1999 Canadian Recommendations for the Management of Hypertension. , 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[12] L. Poston,et al. British Hypertension Society guidelines for hypertension management 1999: summary , 1999, BMJ.
[13] Bruce Neal,et al. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. , 1999, Journal of hypertension.
[14] Z Vokó,et al. J-shaped relation between blood pressure and stroke in treated hypertensives. , 1999, Hypertension.
[15] Lippincott Williams Wilkins,et al. 1993 guidelines for the management of mild hypertension. Memorandum from a World Health Organization/International Society of Hypertension meeting. Guidelines Subcommittee of the WHO/ISH Mild Hypertension Liaison Committee. , 1993, Hypertension.
[16] J. Staessen,et al. Update on the systolic hypertension in Europe (Syst-Eur) trial. The Syst-Eur Investigators. , 1999, Hypertension.
[17] J A Staessen,et al. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension , 1998, Journal of hypertension.
[18] J. Webster,et al. Systolic Hypertension in Europe (Syst-Eur) Trial Phase 2: objectives, protocol, and initial progress , 1999, Journal of Human Hypertension.
[19] P. Hamet,et al. Shanghai trial of nifedipine in the elderly (STONE). , 1996, Journal of hypertension.
[20] Bruce Neal,et al. 7th WHO-ISH Meeting on Hypertension, Fukuoka, Japan, 29 September to October, 1998: 1999 World Health Organization - International Society of Hypertension Guidelines for the Management of Hypertension , 1999 .
[21] Detection. The sixth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) , 1997 .
[22] W. Cushman,et al. The role of diastolic blood pressure when treating isolated systolic hypertension. , 1999, Archives of internal medicine.
[23] J. Webster,et al. Subgroup and per-protocol analysis of the randomized European Trial on Isolated Systolic Hypertension in the Elderly. , 1998, Archives of internal medicine.
[24] Joël Ménard,et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.
[25] S. Collins. THE PUBLICATION COMMITTEE. , 1917, California state journal of medicine.